Study guide / results, risks, and limits
What did tesamorelin studies find during HIV care?
Trials of people with HIV measured belly fat and liver fat. Approval came in 2010 for one narrow use.
What did the main studies measure?
Deep belly fat was the main measure in studies of people with HIV. They weren't ordinary weight-loss trials.
Tesamorelin copies a brain hormone that starts a clear body process. That hormone asks a small gland just below the brain to act.
Growth hormone then enters circulation from that gland. Next, the liver makes IGF-1, a growth protein tracked by blood tests.
One trial found about 15% less deep belly fat. Another found about a third less liver fat.
FDA approval covers excess belly fat during HIV care. Your doctor would have to weigh any other use.
How much fat changed with tesamorelin?
The largest early 26-week trial followed 412 adults with HIV. It compared tesamorelin 2 mg/day with placebo, an inactive shot.
Deep belly fat fell 15.2% with tesamorelin. The placebo group rose 5.0% instead [1].
Triglycerides dropped by 50 milligrams per deciliter on the blood test. Placebo produced a rise of 9 milligrams per deciliter [1].
Blood tests showed more IGF-1, the liver's growth protein, with possible benefits and risks. Deep belly fat stayed 18% lower in the 52-week work [2].
The change was limited to the deeper fat. Skin fat remained, and body weight barely moved [1].
A 2026 review joined five trials involving people with HIV. Scans still showed less belly and liver fat [12].
Its 95% range allowed for doubt around the best estimate. Even the low end still pointed to less deep belly fat.
Two were Phase 3 trials, large late tests used for approval. A 2024 trial also covered newer HIV drugs.
The matching study sits beside every bracketed number. The next page explains what tesamorelin does inside the body.
What is tesamorelin used for, and what remains unproved?
FDA approval covers one small part of care. Tesamorelin isn't an all-purpose weight drug.
In 2010, approval covered excess belly fat in people with HIV [5]. Doctors call this misplaced body fat lipodystrophy.
General weight loss, anti-aging, sports, and other fatty liver lack FDA approval. Those uses haven't been proved [5].
Human study outside HIV care remains small. One study included only 13 healthy men [4].
A trial in older adults checked thinking skills. It wasn't a broad test of ordinary weight loss.
A 2026 review found no sound support for using it on bones or joints [11]. That proposed use still hasn't been proved.
Powder marked for research is meant for laboratory work. It isn't finished prescription medicine for your care.
Is tesamorelin FDA approved for more than one illness?
Tesamorelin is approved, but only for one use. FDA approval came in 2010 for excess belly fat in people with HIV [5].
Doctors call that fat problem lipodystrophy. Tesamorelin is a prescription drug for that illness.
Ordinary weight loss and anti-aging fall outside the approval. Better thinking and other fatty liver do too [5].
A 2024 trial studied people with HIV taking newer HIV drugs [10]. The trial added proof inside HIV care only.
That limit matters for your choice. A possible body effect isn't an approved use.
Is tesamorelin safe, and who has added risk?
The safety record isn't a clean bill of health. A major review found no known liver harm [5].
The shot area could become sore or red. Blood sugar changes stayed small over 52 weeks [2].
Tesamorelin raises IGF-1, the liver's growth protein. Active cancer bars its use, and long-term cancer risk remains unclear [5].
Pregnancy also bars its use. Animal studies found harmful brain fluid in the offspring.
People with high blood sugar may need blood tests. The drug is barred from organized sport due to its growth-hormone effect.
The research page lists the reported side effects. Your own risks need a direct talk with your doctor.
Where does tesamorelin proof stop?
Three gaps matter when you weigh a result. First, deep belly fat returns after tesamorelin stops [2].
Second, every main trial member lived with HIV. Other groups lack a large trial showing the same loss [5].
Third, liver studies measured fat at that time. They didn't prove less scarring or better health years later [6].
Powder sold only for research isn't approved personal medicine. The reported side effects page gives the known warnings.
The tesamorelin and liver fat page explains those studies. Each bracketed number matches the reference list.